Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Effective expansion of alloantigen-specific Foxp3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction
2006 StandoutNobel
Gene expression profiling of breast cell lines identifies potential new basal markers
2005
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Breast cancer
2019 Standout
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
2005
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
1991
CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene
2004 StandoutNobel
Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide
2002
Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow
2004
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Comparison of magnetic resonance imaging and 67gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma
2007
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
2001
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
2003 StandoutNobel
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Patient-reported and physician-estimated adherence to HAART
2004
Predictors of Pain and Fatigue in the Year Following Diagnosis Among Elderly Cancer Patients
2001
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches
2004
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation
2001
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients
2012
DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: Current data and issues on study design
2006
The current understanding of the molecular determinants of inflammatory breast cancer metastasis
2005
The benefits of being present: Mindfulness and its role in psychological well-being.
2003 Standout
Supportive Cryotherapy: A Review From Head to Toe
2013
Recent Advances in the Treatment of Breast Cancer
2018
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
IMPLICATIONS OF RECENT INSIGHTS INTO THE PATHOPHYSIOLOGY OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
2000
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Complement
2001 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells
2004 StandoutNobel
Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
2000
Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells
2007
A stromal gene signature associated with inflammatory breast cancer
2007
Hypoxia as a factor for 67Ga accumulation in tumour cells
2003
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007 Standout
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma
2003
Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats
2004
Four versus six courses of a dose‐escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation
2005
Cancer of the Ovary
2004 Standout
Adherence to Medication
2005 Standout
Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
2009 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Inflammatory and immune pathways in the pathogenesis of periodontal disease
2013 Standout
Breast Cancer Statistics, 2022
2022 Standout
Cytokine Expression in Periodontal Health and Disease
1998
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Human Anti-Animal Antibody Interferences in Immunological Assays
1999
Self-Reported Quality of Life of Individual Cancer Patients: Concordance of Results With Disease Course and Medical Records
2001
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
CD4+regulatory cells as a potential immunotherapy
2005 StandoutNobel
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.
1997
Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity
2006 StandoutNobel
The Risk of Determining Risk with Multivariable Models
1993 Standout
Cardiotoxicity of Cancer Therapy
2005
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
1999
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
2000 Standout
CD4+CD25+Foxp3+ T Cells and CD4+CD25−Foxp3+ T Cells in Aged Mice
2006 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
2002
Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice
2011 StandoutNobel
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Gene Expression Profiling of Breast Cancer
2008
Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation
1991
B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions
2004 StandoutNobel
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of Jacques Camerlo being referenced
Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery
1996
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
2017
Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy
2004
Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data
1994
Weekly administration of docetaxel for symptomatic metastatic hormone‐refractory prostate carcinoma
2003
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration
1996
Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy
2002
Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy
1999
Second Neoplasms Following High-dose Chemotherapy and Autologous Stem Cell Transplantation for Malignant Lymphomas: A Report of Six Cases in a Cohort of 171 Patients from a Single Institution
1998
Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care
1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
1997
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma
1999
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
2001
Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy
2001
Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors.
2003
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation.
1998
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
1996
Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation
1986
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies.
1996
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.
1991